Veterinary Medicines

Xylapan 20 mg/ml Roztwór do wstrzykiwań

Authorised
  • Xylazine
Download as PDF

Product identification

Medicine name:
Xylapan 20 mg/ml Roztwór do wstrzykiwań
Active substance:
  • Xylazine
Target species:
  • Dog
  • Cat
  • Horse
  • Cattle
Route of administration:
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Xylazine
    20.00
    milligram(s)/millilitre
    /
    1.00
    milligram(s)/millilitre
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
    • Cat
    • Horse
      • Meat and offal
        0
        day
    • Cattle
      • Meat and offal
        0
        day
  • Intramuscular use
    • Dog
    • Cat
    • Horse
      • Meat and offal
        0
        day
    • Cattle
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM92
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol Biowet Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol Biowet Sp. z o.o.
Responsible authority:
  • URPL
Authorisation number:
  • 1185
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 26/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."